REGEnLIFE

REGEnLIFE is a neurotechnology company based in Paris, France, with a presence in Prior Lake, Minnesota, USA. The company specializes in developing innovative medical devices that utilize photobiomodulation, a light-based therapy, to target neuroinflammation associated with various neurological disorders, including Alzheimer’s disease, depression, traumatic brain injuries, and multiple sclerosis. The company creates specialized photonic stimulation devices, such as a helmet designed to deliver light through the skull to the brain. Their light therapy solutions aim to reduce neuroinflammation and improve symptoms related to neurological diseases. REGEnLIFE is actively conducting clinical trials to validate the effectiveness of their therapies and plans to expand access to these treatments for home use, enhancing convenience for patients. Their primary customers include healthcare providers and hospitals focused on neurological care, with a vision to eventually reach individual patients managing chronic conditions.

• Employees 13
• Founded 2016